|
[1]
|
National Center for Complementary and Alternative Medicine (US) (2013) Complementary, Alternative, or Integrative Health: What’s in a Name?
http://nccam.nih.gov/health/whatiscam
|
|
[2]
|
National Center for Complementary and Alternative Medicine (US) (2006) Herbal Supplements: Consider Safety, Too. http://img.thebody.com/nccam/safety.pdf
|
|
[3]
|
Bent, S. (2008) Herbal Medicine in the United States: Review of Efficacy, Safety, and Regulation: Grand Rounds at University of California, San Francisco Medical Center. Journal of General Internal Medicine, 23, 854-859.
http://dx.doi.org/10.1007/s11606-008-0632-y
|
|
[4]
|
Cupp, M.J. (1999) Herbal Remedies: Adverse Effects and Drug Interactions. American Family Physician, 59, 1239-1245.
|
|
[5]
|
Wu, C.H., Wang, C.C. and Kennedy, J. (2011) Changes in Herb and Dietary Supplement Use in the US Adult Population: A Comparison of the 2002 and 2007 National Health Interview Surveys. Clinical Therapeutics, 33, 1749-1758.
http://dx.doi.org/10.1016/j.clinthera.2011.09.024
|
|
[6]
|
American Psychiatric Association (2013) Diagnostic and Statistical Manual of Mental Disorders. 5th Edition, American Psychiatric Association, Arlington.
|
|
[7]
|
Kessler, R.C., Aguilar-Gaxiola, S., Alonso, J., et al. (2009) The Global Burden of Mental Disorders: An Update from the WHO World Mental Health (WMH) Surveys. Epidemiologia e Psichiatria Sociale, 18, 23-33.
http://dx.doi.org/10.1017/S1121189X00001421
|
|
[8]
|
Haller, C., Kearney, T., Bent, S., Ko, R., Benowitz, N. and Olson, K. (2008) Dietary Supplement Adverse Events: Report of a One-Year Poison Center Surveillance Project. Journal of Medical Toxicology, 4, 84-92.
http://dx.doi.org/10.1007/BF03160960
|
|
[9]
|
Bandelow, B., Sher, L., Bunevicius, R., et al. (2012) Guidelines for the Pharmacological Treatment of Anxiety Disorders, Obsessive-Compulsive Disorder and Posttraumatic Stress Disorder in Primary Care. International Journal of Psychiatry in Clinical Practice, 16, 77-84.
http://dx.doi.org/10.3109/13651501.2012.667114
|
|
[10]
|
Sinclair, L.I., Christmas, D.M., Hood, S.D., et al. (2009) Antidepressant-Induced Jitteriness/Anxiety Syndrome: Systematic Review. The British Journal of Psychiatry, 194, 483-490.
http://dx.doi.org/10.1192/bjp.bp.107.048371
|
|
[11]
|
Boyer, E.W. and Shannon, M. (2005) The Serotonin Syndrome. The New England Journal of Medicine, 352, 1112-1120.
http://dx.doi.org/10.1056/NEJMra041867
|
|
[12]
|
Birmes, P., Coppin, D., Schmitt, L. and Lauque, D. (2003) Serotonin Syndrome: A Brief Review. Canadian Medical Association Journal, 168, 1439-1442.
|
|
[13]
|
Evans, C.E. and Sebastian, J. (2007) Serotonin Syndrome. Emergency Medicine Journal, 24, e20.
http://dx.doi.org/10.1136/emj.2006.040550
|
|
[14]
|
Mills, K.C. (1997) Serotonin Syndrome. A Clinical Update. Critical Care Clinics, 13, 763-783.
http://dx.doi.org/10.1016/S0749-0704(05)70368-7
|
|
[15]
|
Ables, A.Z. and Nagubilli, R. (2010) Prevention, Diagnosis, and Management of Serotonin Syndrome. American Family Physician, 8, 1139-1142.
|
|
[16]
|
Linde, K. (2009) St. John’s Wort—An Overview. Forschende Komplementärmedizin, 16, 146-155.
http://dx.doi.org/10.1159/000209290
|
|
[17]
|
Henderson, L., Yue, Q.Y., Bergquist, C., Gerden, B. and Arlett, P. (2002) St John’s Wort (Hypericum perforatum): Drug Interactions and Clinical Outcomes. British Journal of Clinical Pharmacology, 54, 349-356.
http://dx.doi.org/10.1046/j.1365-2125.2002.01683.x
|
|
[18]
|
Hammerness, P., Basch, E., Ulbricht, C., Barrette, E.P., Foppa, I., Basch, S., et al. (2003) St John’s Wort: A Systematic Review of Adverse Effects and Drug Interactions for the Consultation Psychiatrist. Psychosomatics, 44, 271-282.
http://dx.doi.org/10.1176/appi.psy.44.4.271
|
|
[19]
|
Knüppel, L. and Linde, K. (2004) Adverse Effects of St. John’s Wort: A Systematic Review. Journal of Clinical Psychiatry, 65, 1470-1479.
http://dx.doi.org/10.4088/JCP.v65n1105
|
|
[20]
|
Dannawi, M. (2002) Possible Serotonin Syndrome after Combination of Buspirone and St. John’s Wort. Journal of Psychopharmacology, 16, 401.
http://dx.doi.org/10.1177/026988110201600420
|
|
[21]
|
Bonetto, N., Santelli, L., Battistin, L. and Cagnin, A. (2007) Serotonin Syndrome and Rhabdomyolysis Induced by Concomitant Use of Triptans, Fluoxetine and Hypericum. Cephalalgia, 27, 1421-1423.
http://dx.doi.org/10.1111/j.1468-2982.2007.01430.x
|
|
[22]
|
Lantz, M.S., Buchalter, E. and Giambanco, V. (1999) St. John’s Wort and Antidepressant Drug Interactions in the Elderly. Journal of Geriatric Psychiatry and Neurology, 12, 7-10.
http://dx.doi.org/10.1177/089198879901200103
|
|
[23]
|
Gordon, J.B. (1998) SSRIs and St. John’s Wort: Possible Toxicity? American Family Physician, 57, 950.
|
|
[24]
|
Bryant, S.M. and Kolodchak, J. (2004) Serotonin Syndrome Resulting from an Herbal Detox Cocktail. The American Journal of Emergency Medicine, 22, 625-626.
http://dx.doi.org/10.1016/j.ajem.2004.09.013
|
|
[25]
|
Beckman, S.E., Sommi, R.W. and Switzer, J. (2000) Consumer Use of St. John’s Wort: A Survey on Effectiveness, Safety, and Tolerability. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 20, 568-574.
http://dx.doi.org/10.1592/phco.20.6.568.35152
|
|
[26]
|
Parker, V., Wong, A.H., Boon, H.S. and Seeman, M.V. (2001) Adverse Reactions to St. John’s Wort. Canadian Journal of Psychiatry, 46, 77-79.
|
|
[27]
|
Brown, T.M. (2000) Acute St. John’s Wort Toxicity. The American Journal of Emergency Medicine, 18, 231-232.
http://dx.doi.org/10.1016/S0735-6757(00)90030-5
|
|
[28]
|
Markowitz, J.S., Donovan, J.L., DeVane, C.L., Taylor, R.M., Ruan, Y., Wang, J.S., et al. (2003) Effect of St. John’s Wort on Drug Metabolism by Induction of Cytochrome P450 3A4 Enzyme. The Journal of the American Medical Association, 290, 1500-1504.
http://dx.doi.org/10.1001/jama.290.11.1500
|
|
[29]
|
Johne, A., Schmider, J., Brockmöller, J., Stadelmann, A., Störmer, E., Bauer, S., et al. (2002) Decreased Plasma Levels of Amitriptyline and Its Metabolites on Comedication with an Extract from St. John’s Wort (Hypericum perforatum). Journal of Clinical Psychopharmacology, 22, 46-54.
http://dx.doi.org/10.1097/00004714-200202000-00008
|
|
[30]
|
Natural Medicine Comprehensive Database (US) (2011) SAMe Full Monograph.
http://naturaldatabase.therapeuticresearch.com.proxy.libraries.rutgers.edu/nd/Search.aspx?cs=CEPDA
~SFS&s=ND&pt=100&sh=1&id=786
|
|
[31]
|
Mischoulon, D. and Fava, M. (2002) Role of S-Adenosyl-L-Methionine in the Treatment of Depression: A Review of the Evidence. The American Journal of Clinical Nutrition, 76, 1158S-1161S.
|
|
[32]
|
Saletu, B., Anderer, P., Di Padova, C., Assandri, A. and Saletu-Zyhlarz, G.M. (2002) Electrophysiological Neuroimaging of the Central Effects of S-Adenosyl-L-Methionine by Mapping of Electroencephalograms and Event-Related Potentials and Low-Resolution Brain Electromagnetic Tomography. The American Journal of Clinical Nutrition, 76, 1162S-1171S.
|
|
[33]
|
Arnold, O., Saletu, B., Anderer, P., di Padova, C., Corrado, M. and Saletu-Zyhlarz, G.M. (2005) Double-Blind, Placebo-Controlled Pharmacodynamic Studies with a Nutraceutical and a Pharmaceutical Dose of Ademetionine (SAMe) in Elderly Subjects, Utilizing EEG Mapping and Psychometry. European Neuropsychopharmacology, 15, 533-543.
http://dx.doi.org/10.1016/j.euroneuro.2005.01.004
|
|
[34]
|
Di Rocco, A., Rogers, J.D., Brown, R., Werner, P. and Bottiglieri, T. (2000) S-Adenosyl-Methionine Improves Depression in Patients with Parkinson’s Disease in an Open-Label Clinical Trial. Movement Disorders, 15, 1225-1229.
|
|
[35]
|
Papakostas, G.I., Mischoulon, D., Shyu, I., Alpert, J.E. and Fava, M. (2010) S-Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders with Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial. The American Journal of Psychiatry, 167, 942-948.
http://dx.doi.org/10.1176/appi.ajp.2009.09081198
|
|
[36]
|
Iruela, L.M., Minguez, L., Merino, J. and Monedero, G. (1993) Toxic Interaction of S-Adenosylmethionine and Clomipramine. The American Journal of Psychiatry, 150, 522.
|
|
[37]
|
Birdsall, T.C. (1998) 5-Hydroxytryptophan: A Clinically-Effective Serotonin Precursor. Alternative Medicine Review, 3, 271-280.
|
|
[38]
|
Turner, E.H., Loftis, J.M. and Blackwell, A.D. (2006) Serotonin a la Carte: Supplementation with the Serotonin Precursor 5-Hydroxytryptophan. Pharmacology & Therapeutics, 109, 325-338.
http://dx.doi.org/10.1016/j.pharmthera.2005.06.004
|
|
[39]
|
Natural Medicine Comprehensives Database (US) (2014) L-Tryptophan Full Monograph.
http://naturaldatabase.therapeuticresearch.com.proxy.libraries.rutgers.edu/nd/
Search.aspx?cs=CEPDA~SFS&s=ND&pt=100&sh=1&id=326
|
|
[40]
|
Natural Medicine Comprehensives Database (US) (2014) 5-HTP Full Monograph.
http://naturaldatabase.therapeuticresearch.com.proxy.libraries.rutgers.edu/nd/Search.aspx?cs=CEPDA
~SFS&s=ND&pt=100&sh=5&id=794
|
|
[41]
|
Van Woert, M.H. and Sethy, V.H. (1975) Therapy of Intention Myoclonus with L-5-Hydroxytryptophan and a Peripheral Decarboxylase Inhibitor, MK 486. Neurology, 25, 135-140.
http://dx.doi.org/10.1212/WNL.25.2.135
|
|
[42]
|
Van Woert, M.H., Rosenbaum, D., Howieson, J. and Bowers Jr., M.B. (1977) Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and Carbidopa. The New England Journal of Medicine, 296, 70-75.
http://dx.doi.org/10.1056/NEJM197701132960203
|
|
[43]
|
Thal, L.J., Sharpless, N.S., Wolfson, L. and Katzman, R. (1980) Treatment of Myoclonus with L-5-Hydroxytryptophan and Carbidopa: Clinical, Electrophysiological, and Biochemical Observations. Annals of Neurology, 7, 570-576.
http://dx.doi.org/10.1002/ana.410070611
|
|
[44]
|
Haskell, C.F., Dodd, F.L., Wightman, E.L. and Kennedy, D.O. (2013) Behavioral Effects of Compounds Co-Consumed in Dietary Forms of Caffeinated Plants. Nutrition Research Review, 26, 49-70.
http://dx.doi.org/10.1017/S0954422413000036
|
|
[45]
|
Hechman, M.A., Weil, J. and Mejia, E.G. (2010) Caffeine (1,3,7-Trimethylxanthine) in Foods: A Comprehensive Review on Consumption, Functionality, Safety, and Regulatory Matters. Journal of Food Science, 75, R77-R87.
http://dx.doi.org/10.1111/j.1750-3841.2010.01561.x
|
|
[46]
|
DRUGDEX System Micromedex 2.0. (2014) Caffeine.
http://www.micromedexsolutions.com.proxy.libraries.rutgers.edu/micromedex2/librarian/ND_T/
evidencexpert/ND_PR/evidencexpert/CS/10955F/ND_AppProduct/evidencexpert/DUPLICATION
SHIELDSYNC/BEFE12/ND_PG/evidencex-pert/ND_B/evidencexpert/ND_P/evidencexpert/PFActionId/evidencexpert.
IntermediateToFullDocumentLink/docId/1291/contentSetId/31/title/CAFFEINE/servicesTitle/
CAFFEINE
|
|
[47]
|
Lara, D.R. (2010) Caffeine, Mental Health, and Psychiatric Disorders. Journal of Alzheimer’s Disease, 20, S239-248.
|
|
[48]
|
Childs, E. and de Wit, H. (2006) Subjective, Behavioral, and Physiological Effects of Acute Caffeine in Light, Nondependent Caffeine Users. Psychopharmacology(Berlin), 185, 514-523.
http://dx.doi.org/10.1007/s00213-006-0341-3
|
|
[49]
|
Nardi, A.E., Lopes, F.L., Freire, R.C., Veras, A.B., Nascimento, I., Valença, A.M., et al. (2009) Panic Disorder and Social Anxiety Disorder Subtypes in a Caffeine Challenge Test. Psychiatry Research, 169, 149-153.
http://dx.doi.org/10.1016/j.psychres.2008.06.023
|
|
[50]
|
Bergin, J.E. and Kendler, K.S. (2012) Common Psychiatric Disorders and Caffeine Use, Tolerance, and Withdrawal: An Examination of Shared Genetic and Environment Effects. Twin Research and Human Genetics, 15, 473-482.
http://dx.doi.org/10.1017/thg.2012.25
|
|
[51]
|
Childs, E., Hohoff, C., Deckert, J., Xu, K., Badner, J. and de Wit, H. (2008) Association between ADROA2A and DRD2 Polymorphisms and Caffeine-Induced Anxiety. Neuropsychopharmacology, 33, 2791-2800.
http://dx.doi.org/10.1038/npp.2008.17
|
|
[52]
|
Bhatti, S.K., O’Keefe, J.H. and Lavie, C.J. (2013) Coffee and Tea: Perks for Health and Longevity? Current Opinion in Clinical Nutrition and Metabolic Care, 16, 688-697.
http://dx.doi.org/10.1097/MCO.0b013e328365b9a0
|
|
[53]
|
Ellam, S. and Williamson, G. (2013) Cocoa and Human Health. Annual Review of Nutrition, 33, 105-128.
http://dx.doi.org/10.1146/annurev-nutr-071811-150642
|
|
[54]
|
De Araujo, Q.R., Gattward, J.N., Almoosawi. S., Silva, M.D.C., Dantas, P.A. and Araujo Jr., Q.R. (2013) Cacao and Human Health: From Head to Foot—A Review. Critical Reviews in Food Science and Nutrition, In Press.
|
|
[55]
|
Natural Medicine Comprehensives Database (US) (2013) Cocoa Full Monograph.
http://naturaldatabase.therapeuticresearch.com.proxy.libraries.rutgers.edu/nd/
Search.aspx?cs=CEPDA~SFS&s=ND&pt=100&id=812&ds=&name=COCOA&searchid=47308599
|
|
[56]
|
Latif, R. (2013) Health Benefits of Cocoa. Current Opinion in Clinical Nutrition and Metabolic Care, 16, 669-674.
http://dx.doi.org/10.1097/MCO.0b013e328365a235
|
|
[57]
|
Burdock, G.A., Carabin, I.G. and Crincoli, C.M. (2009) Safety Assessment of Kola Nut Extract as a Food Ingredient. Food and Chemical Toxicology, 47, 1725-1732.http://dx.doi.org/10.1016/j.fct.2009.04.019
|
|
[58]
|
Natrual Medicine Comprehensive Database (US) (2013) Cola Nut Full Monograph.
http://naturaldatabase.therapeuticresearch.com.proxy.libraries.rutgers.edu/nd/Search.
aspx?cs=CEPDA~SFS&s=ND&pt=100&id=937&ds=&name=COLA+NUT&searchid=47308599
|
|
[59]
|
Schimpl, F.C., da Silva, J.F., Goncalves, J.F. and Mazzafera, P. (2013) Guarana: Revisiting a Highly Caffeinated Plant from the Amazon. Journal of Ethnopharmacology, 150, 14-31.
http://dx.doi.org/10.1016/j.jep.2013.08.023
|
|
[60]
|
Natural Medicine Comprehensives Database (US) (2012) Guarana Full Monograph.
http://naturaldatabase.therapeuticresearch.com.proxy.libraries.rutgers.edu/nd/Search.aspx?
cs=CEPDA~SFS&s=ND&pt=100&id=935&ds=&name=GUARANA&searchid=47308599
|
|
[61]
|
Silvestrini, G.I., Marino, F. and Cosentino, M. (2013) Effects of a Commercial Product Containing Guaraná on Psychological Well-Being, Anxiety and Mood: A Single-Blind, Placebo-Controlled Study in Healthy Subjects. Journal of Negative Results in BioMedicine, 12, 9.
http://dx.doi.org/10.1186/1477-5751-12-9
|
|
[62]
|
Berigan, T. (2005) An Anxiety Disorder Secondary to Energy Drinks: A Case Report. Psychiatry, 2, 10.
|
|
[63]
|
Wolk, B.J., Ganetsky, M. and Babu, K.M. (2012) Toxicity of Energy Drinks. Current Opinion in Pediatrics, 24, 243-251.
http://dx.doi.org/10.1097/MOP.0b013e3283506827
|
|
[64]
|
Heck, C.I. and De Mejia, E.G. (2007) Yerba Mate Tea (Ilex paraguariensis): A Comprehensive Review on Chemistry, Health Implications, and Technological Considerations. Journal of Food Science, 72, R138-R151.
http://dx.doi.org/10.1111/j.1750-3841.2007.00535.x
|
|
[65]
|
Bracesco, N., Sanchez, A.G., Contreras, V., Menini, T. and Gugliucci, A. (2011) Recent Advances on Ilex paraguariensis Research: Mini Review. Journal of Ethnopharmacology, 136, 378-384.
http://dx.doi.org/10.1016/j.jep.2010.06.032
|
|
[66]
|
Natural Medicine Comprehensives Database (US) (2013) Mate Full Monograph.
http://naturaldatabase.therapeuticresearch.com.proxy.libraries.rutgers.edu/nd/Search.aspx?
cs=CEPDA~SFS&s=ND&pt=100&id=828&ds=&name=MATE&searchid=47308599
|
|
[67]
|
Natural Standard: The Authority on Integrative Medicine (US) (2014) Khat.
https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/k/khat/
professional.aspx
|
|
[68]
|
Wabe, N.T. (2011) Chemistry, Pharmacology, and Toxicology of Khat (Catha edulis Forsk.): A Review. Addiction of Health, 3, 137-149.
|
|
[69]
|
Kalix, P. (1991) The Pharmacology of Psychoactive Alkaloids from Ephedra and Catha. Journal of Ethnopharmacology, 32, 201-208.
http://dx.doi.org/10.1016/0378-8741(91)90119-X
|
|
[70]
|
Patel, N.B. (2000) Mechanism of Action of Cathinone: The Active Ingredient of Khat (Catha edulis). East African Medical Journal, 77, 329-332.
|
|
[71]
|
Kalix, P. (1994) Khat, an Amphetamine-Like Stimulant. Journal of Psychoactive Drugs, 26, 69-74.
http://dx.doi.org/10.1080/02791072.1994.10472604
|
|
[72]
|
Al-Motarreb, A., Baker, K. and Broadley, K. (2002) Khat: Pharmacological and Medical Aspects and Its Social Use in Yemen. Phytotherapy Research, 16, 403-413.
http://dx.doi.org/10.1002/ptr.1106
|
|
[73]
|
Kalix, P. (1992) Cathinone, a Natural Amphetamine. Pharmacology & Toxicology, 70, 77-86.
http://dx.doi.org/10.1111/j.1600-0773.1992.tb00434.x
|
|
[74]
|
Kelly, J.P. (2011) Cathinone Derivatives: A Review of Their Chemistry, Pharmacology and Toxicology. Drug Testing and Analysis, 3, 439-453.
http://dx.doi.org/10.1002/dta.313
|
|
[75]
|
Geisshusler, S. and Brenneisen, R. (1987) The Content of Psychoactive Phenylpropyl and Phenylpentenyl Khatamines in Catha edulis Forsk. of Different Origin. Journal of Ethnopharmacology, 19, 269-277.
http://dx.doi.org/10.1016/0378-8741(87)90004-3
|
|
[76]
|
Brenneisen, R., Fisch, H.U., Koelbing, U., Geisshusler, S. and Kalix, P. (1990) Amphetamine-Like Effects in Humans of the Khat Alkaloid Cathinone. British Journal of Clinical Pharmacology, 30, 825-828.
http://dx.doi.org/10.1111/j.1365-2125.1990.tb05447.x
|
|
[77]
|
Martin, W.R., Sloan, J.W., Sapira, J.D. and Jasinski, D.R. (1971) Physiologic, Subjective, and Behavioral Effects of Amphetamine, Methamphetamine, Ephedrine, Phenmetrazine, and Methylphenidate in Man. Clinical Pharmacology & Therapeutics, 12, 245-258.
|
|
[78]
|
Jager, A.D. and Sireline, L. (1994) Natural History of Khat Psychosis. Australian and New Zealand Journal of Psychiatry, 28, 331-332.
http://dx.doi.org/10.3109/00048679409075648
|
|
[79]
|
The WHO Expert Committee on Drug Dependence (ECDD) (2006) Assessment of Khat (Catha edulis Forsk.).
http://www.who.int/medicines/areas/quality_safety/4.4KhatCritReview.pdf
|
|
[80]
|
Hassan, N.A., Gunaid, A.A., El Khally, F.M. and Murray-Lyon, I.M. (2002) The Effect of Chewing Khat Leaves on Human Mood. Saudi Medical Journal, 23, 850-853.
|
|
[81]
|
Eckersley, W., Salmon, R. and Gebru, M. (2010) Khat, Driver Impairment and Road Traffic Injuries: A View from Ethiopia. Bulletin of the World Health Organization, 88, 235-236.
http://dx.doi.org/10.2471/BLT.09.067512
|
|
[82]
|
Randall, T. (1993) Khat Abuse Fuels Somali Conflict, Drains Economy. The Journal of the American Medical Association, 269, 12-15.
http://dx.doi.org/10.1001/jama.1993.03500010014004
|
|
[83]
|
Drug Enforcement Agency (2012) Drug Fact Sheet. Khat.
http://www.justice.gov/dea/druginfo/drug_data_sheets/Khat.pdf
|
|
[84]
|
Natural Medicine Comprehensives Database (US) (2014) Yohimbe Full Monograph.
http://naturaldatabase.therapeuticresearch.com/nd/Search.aspx?cs=CEPDA
~SFS&s=ND&pt=100&id=759&ds=&name=YOHIMBE&searchid=47301122
|
|
[85]
|
Kunelius, P., Häkkinen, J. and Lukkarinen, O. (1997) Is High-Dose Yohimbine Hydrochloride Effective in the Treatment of Mixed-Type Impotence? A Prospective, Randomized, Controlled Double-Blind Crossover Study. Urology, 49, 441-444.
http://dx.doi.org/10.1016/S0090-4295(96)00505-5
|
|
[86]
|
Tam, S.W., Worcel, M. and Wyllie, M. (2001) Yohimbine: A Clinical Review. Pharmacology & Therapeutics, 91, 215-243.
http://dx.doi.org/10.1016/S0163-7258(01)00156-5
|
|
[87]
|
Jacobsen, F.M. (1992) Fluoxetine-Induced Sexual Dysfunction and an Open Trial of Yohimbine. The Journal of Clinical Psychiatry, 53, 119-122.
|
|
[88]
|
Ernst, E. and Pittler, M.H. (1998) Yohimbine for Erectile Dysfunction: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. The Journal of Urology, 159, 433-436.
http://dx.doi.org/10.1016/S0022-5347(01)63942-9
|
|
[89]
|
Teloken, C., Rhoden, E.L., Sogari, P., Dambros, M. and Souto, C.A. (1998) Therapeutic Effects of High Dose Yohimbine Hydrochloride on Organic Erectile Dysfunction. The Journal of Urology, 159, 122-124.
http://dx.doi.org/10.1016/S0022-5347(01)64032-1
|
|
[90]
|
Natural Standard: The Authority on Integrative Medicine (US) (2014) Yohimbe Bark Extract.
https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/y/
yohimbe-bark-extract/professional.aspx
|
|
[91]
|
Morales, A. (2000) Yohimbine in Erectile Dysfunction: The Facts. International Journal of Impotence Research, 12, S70-S74.
http://dx.doi.org/10.1038/sj.ijir.3900508
|
|
[92]
|
Betz, J.M., White, K.D. and der Marderosian A.H. (1995) Gas Chromatographic Determination of Yohimbine in Commercial Yohimbe Products. Journal of AOAC International, 78, 1189-1194.
|
|
[93]
|
Tanaka, M., Yoshida, M., Emoto, H. and Ishii, H. (2000) Noradrenaline Systems in the Hypothalamus, Amygdala and Locus Coeruleus Are Involved in the Provocation of Anxiety: Basic Studies. European Journal of Pharmacology, 405, 397-406.
http://dx.doi.org/10.1016/S0014-2999(00)00569-0
|
|
[94]
|
Kearney, T., Tu, N. and Haller, C. (2010) Adverse Drug Events Associated with Yohimbine-Contaming Products: A Retrospective Review of the California Poison Control System Reported Cases. The Annals of Pharmacotherapy, 44, 1022-1029.
http://dx.doi.org/10.1345/aph.1P060
|
|
[95]
|
Susset, J.G., Tessier, C.D., Wincze, J., Bansal, S., Malhotra, C. and Schwacha M.G. (1989) Effect of Yohimbine Hydrochloride on Erectile Impotence: A Double Blind Study. The Journal of Urology, 141, 1360-1363.
|
|
[96]
|
Henauer, S.A., Gillespie, H.K. and Hollister, L.E. (1984) Yohimbine and the Model Anxiety State. The Journal of Clinical Psychiatry, 45, 512-515.
|
|
[97]
|
Charney, D.S., Heninger, G.R. and Redmond, D.E. (1983) Yohimbine Induced Anxiety And Increased Noadrenergic Function in Humans: Effects of Diazepam and Clonidine. Life Sciences, 33, 19-29.
http://dx.doi.org/10.1016/0024-3205(83)90707-5
|
|
[98]
|
Vasa, R.A., Pine, D.S., Masten, C.L., Vythilingam, M., Collin, C., Charney, D.S., et al. (2009) Effects of Yohimbine and Hydrocortisone on Panic Symptoms, Autonomic Responses and Attention to Threat in Healthy Adults. Psychopharmacology(Berlin), 204, 445-455.
http://dx.doi.org/10.1007/s00213-009-1475-x
|
|
[99]
|
Kaplan, J.S., Arnkoff, D.B., Glass, C.R., Tinsley, R., Geraci, M., Hernandez, E., et al. (2012) Avoidant Coping in Panic Disorder: A Yohimbine Biological Challenge Study. Anxiety, Stress & Coping: An International Journal, 25, 425-442.
http://dx.doi.org/10.1080/10615806.2011.609587
|
|
[100]
|
Charney, D.S., Woods, S.W., Krystal, J.H., Nagy, L.M. and Heninger, G.R. (1992) Noradrenergic Neuronal Dysregulation in Panic Disorder: The Effects of Intravenous Yohimbine and Clonidine in Panic Disorder Patients. Acta Psychiatrica Scandinavica, 86, 273-282.
http://dx.doi.org/10.1111/j.1600-0447.1992.tb03266.x
|
|
[101]
|
Price, L.H., Charney, D.S. and Heninger, G.R. (1984) Three Cases of Manic Symptoms Following Yohimbine Administration. The American Journal of Psychiatry, 141, 1267-1268.
|
|
[102]
|
Albus, M., Zahn, T.P. and Breier, A. (1992) Anxiogenic Properties of Yohimbine. I. Behavioral, Physiological and Biochemical Measures. European Archives of Psychiatry and Clinical Neuroscience, 241, 337-344.
http://dx.doi.org/10.1007/BF02191958
|
|
[103]
|
Soni, M.G., Carabin, I.G., Griffiths, J.C. and Burdick, G.A. (2004) Safety of Ephedra: Lessons Learned. Toxicology Letters, 150, 97-110.
http://dx.doi.org/10.1016/j.toxlet.2003.07.006
|
|
[104]
|
Natural Medicine Comprehensives Database (US) (2012) Ephedra.
http://naturaldatabase.therapeuticresearch.com.proxy.libraries.rutgers.edu/nd/Search.aspx?cs=CEPDA~
SFS&s=ND&pt=9&Product=ephedra&btnSearch.x=0&btnSearch.y=0
|
|
[105]
|
National Center for Complementary and Alternative Medicine (US) (2013) Ephedra.
http://nccam.nih.gov/health/ephedra
|
|
[106]
|
Blanck, H., Khan, L. and Serdula, M. (2001) Use of Nonprescription Weight Loss Products: Results from a Multistate Survey. The Journal of the American Medical Association, 286, 930-935.
http://dx.doi.org/10.1001/jama.286.8.930
|
|
[107]
|
Marraffa, J.M. (2011) Goldfrank’s Toxicologic Emergencies. McGraw-Hill Companies, Inc., China.
|
|
[108]
|
Haller, C.A. and Benowitz, N.L. (2000) Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids. The New England Journal of Medicine, 343, 1833-1838.
http://dx.doi.org/10.1056/NEJM200012213432502
|
|
[109]
|
Food and Drug Administration (2004) Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk. Federal Register, 69, 6787-6854.
|
|
[110]
|
Andraws, R., Chawla, P. and Brown, D.L. (2005) Cardiovascular Effects of Ephedra Alkaloids: A Comprehensive Review. Progress in Cardiovascular Diseases, 47, 217-225.
http://dx.doi.org/10.1016/j.pcad.2004.07.006
|
|
[111]
|
Woolf, A.D., Watson, W.A., Smolinski, S. and Litovitz, T. (2005) The Severity of Toxicity Reactions to Ephedra: Comparison to Other Botanical Products and National Trends from 1993-2002. Clinical Toxicology, 43, 347-355.
|
|
[112]
|
Bent, S., Tiedit, T.N., Odden, M.C. and Shlipak, M.G. (2003) The Relative Safety of Ephedra Compared with Other Herbal Products. Annals of Internal Medicine, 138, 468-471.
http://dx.doi.org/10.7326/0003-4819-138-6-200303180-00010
|
|
[113]
|
McBride, B.F., Karapanos, A.K., Krudysz, A., Kluger, J., Coleman, C.I. and White, C.M. (2004) Electrocardiographic and Hemodynamic Effects of a Mutlicomponent Dietary Supplement Containing Ephedra and Caffeine. The Journal of the American Medical Association, 291, 216-221.
http://dx.doi.org/10.1001/jama.291.2.216
|
|
[114]
|
Shekelle, P.G., Hardy, M.L., Morton, S.C., Maglione, M., Mojica, W.A., Suttorp, M.J., et al. (2003) Efficacy and Safety of Ephedra and Ephedrine for Weight Loss and Athletic Performance: A Meta-Analysis. The Journal of the American Medical Association, 289, 1537-1545.
|
|
[115]
|
Bents, R.T. and Marsh, E. (2006) Patterns of Ephedra and Other Stimulant Use in Collegiate Hockey Athletes. International Journal of Sport Nutrition and Exercise Metabolism, 16, 636-643.
|
|
[116]
|
Palamar, J. (2011) How Ephedrine Escaped Regulation in the United States: A Historical Review of Misuse and Associated Policy. Health Policy, 99, 1-9.
http://dx.doi.org/10.1016/j.healthpol.2010.07.007
|
|
[117]
|
Natural Medicine Comprehensives Database (US) (2012) Country Mallow Full Monograph.
http://naturaldatabase.therapeuticresearch.com/nd/Search.aspx?cs=CEPDA
~SFS&s=ND&pt=100&id=837&ds=&name=COUNTRY+MALLOW&searchid=47301122
|
|
[118]
|
Natural Standard: The Authority on Integrative Medicine (US) (2014) Bala.
https://naturalmedicines.therapeuticresearch.com/databases/food,-herbs-supplements/b/bala/professional.aspx
|
|
[119]
|
Franzotti, E.M., Santos, C.V.F., Rodrigues, H.M.S.L., Mourao, M.R., Andrade, M.R. and Antoniolli, A.R. (2000) Anti-Inflammatory, Analgesic Activity and Acute Toxicity of Sida cordifolia L. (Malva-Branca). Journal of Ethnopharmacology, 72, 273-278.
http://dx.doi.org/10.1016/S0378-8741(00)00205-1
|
|
[120]
|
Kanth, V.R. and Diwan, P.V. (1999) Analgesic, Antiinflammatory and Hypoglycaemic Acitivities of Sida cordifolia. Phytotherapy Ressearch, 13, 75-77.
|
|
[121]
|
Momin, M.A., Bellah, S.F., Rahman, S.M., Rahman, A.A., Murshid, G.M. and Emran, T.B. (2014) Phytopharmacological Evaluation of Ethanol Extract of Sida cordifolia L. Roots. Asian Pacific Journal of Tropical Biomedicine, 4, 18-24.
http://dx.doi.org/10.1016/S2221-1691(14)60202-1
|
|
[122]
|
Konaté, K., Bassolé, I.H., Hilou, A., Aworet-Samseny, R., Souza, A., Barro, N., et al. (2012) Toxicity Assessment and Analgesic Activity Investigation of Aqueous Acetone Extracts of Sida acuta Burn F. and Sida cordifolio L. (Malvaceae), Medicinal Plants of Burkina Faso. BMC Complementary & Alternative Medicine, 12, 120-131.
http://dx.doi.org/10.1186/1472-6882-12-120
|
|
[123]
|
Thompson, C.A. (2004) Ephedrine Alkaloids Banned from Dietary Supplements. American Journal of Health-System Pharmacy, 61, 750-753.
|